
Sherman D. Basinger
Examiner (ID: 6218)
| Most Active Art Unit | 3105 |
| Art Unit(s) | 3617, 3612, 2899, 3105, 3102 |
| Total Applications | 3087 |
| Issued Applications | 2627 |
| Pending Applications | 85 |
| Abandoned Applications | 375 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6809545
[patent_doc_number] => 20030199484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Method for the treatment of urinary incontinence'
[patent_app_type] => new
[patent_app_number] => 10/394038
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2070
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10394038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/394038 | Method for the treatment of urinary incontinence | Mar 20, 2003 | Issued |
Array
(
[id] => 753433
[patent_doc_number] => 07018624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels'
[patent_app_type] => utility
[patent_app_number] => 10/389560
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4988
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018624.pdf
[firstpage_image] =>[orig_patent_app_number] => 10389560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/389560 | Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels | Mar 13, 2003 | Issued |
Array
(
[id] => 6874843
[patent_doc_number] => 20030195140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Methods and compositions for improving sleep'
[patent_app_type] => new
[patent_app_number] => 10/387269
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11655
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10387269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/387269 | Methods and compositions for improving sleep | Mar 10, 2003 | Abandoned |
Array
(
[id] => 1192142
[patent_doc_number] => 06730322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-04
[patent_title] => 'Matrices formed of polymer and hydrophobic compounds for use in drug delivery'
[patent_app_type] => B1
[patent_app_number] => 10/384902
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384902 | Matrices formed of polymer and hydrophobic compounds for use in drug delivery | Mar 5, 2003 | Issued |
Array
(
[id] => 6842615
[patent_doc_number] => 20030147962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Matrices formed of polymer and hydrophobic compounds for use in drug delivery'
[patent_app_type] => new
[patent_app_number] => 10/383264
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5179
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10383264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/383264 | Matrices formed of polymer and hydrophobic compounds for use in drug delivery | Mar 4, 2003 | Issued |
Array
(
[id] => 747699
[patent_doc_number] => RE039049
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-03-28
[patent_title] => 'Methods for inhibiting bone loss'
[patent_app_type] => reissue
[patent_app_number] => 10/375341
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7622
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375341
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375341 | Methods for inhibiting bone loss | Feb 26, 2003 | Issued |
Array
(
[id] => 747703
[patent_doc_number] => RE039050
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-03-28
[patent_title] => 'Methods of use for inhibiting bone loss and lowering serum cholesterol'
[patent_app_type] => reissue
[patent_app_number] => 10/375274
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5897
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375274 | Methods of use for inhibiting bone loss and lowering serum cholesterol | Feb 26, 2003 | Issued |
Array
(
[id] => 777669
[patent_doc_number] => RE038968
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-02-07
[patent_title] => 'Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride'
[patent_app_type] => reissue
[patent_app_number] => 10/375339
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7622
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038968.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375339 | Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride | Feb 26, 2003 | Issued |
Array
(
[id] => 7386895
[patent_doc_number] => 20040029845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications'
[patent_app_type] => new
[patent_app_number] => 10/373180
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12603
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373180 | Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications | Feb 25, 2003 | Abandoned |
Array
(
[id] => 6701145
[patent_doc_number] => 20030224025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Skin cosmetic formulations'
[patent_app_type] => new
[patent_app_number] => 10/362059
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14740
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362059 | Skin cosmetic formulations | Feb 19, 2003 | Abandoned |
Array
(
[id] => 6640731
[patent_doc_number] => 20030212130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Creatine ester anti-inflammatory compounds and formulations'
[patent_app_type] => new
[patent_app_number] => 10/365666
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6974
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212130.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365666 | Creatine ester anti-inflammatory compounds and formulations | Feb 11, 2003 | Abandoned |
Array
(
[id] => 7230551
[patent_doc_number] => 20040156870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs'
[patent_app_type] => new
[patent_app_number] => 10/365249
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2820
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365249 | Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs | Feb 10, 2003 | Abandoned |
Array
(
[id] => 6740885
[patent_doc_number] => 20030158254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Engineering absorption of therapeutic compounds via colonic transporters'
[patent_app_type] => new
[patent_app_number] => 10/351291
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19225
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351291 | Engineering absorption of therapeutic compounds via colonic transporters | Jan 22, 2003 | Abandoned |
Array
(
[id] => 6800831
[patent_doc_number] => 20030095995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents'
[patent_app_type] => new
[patent_app_number] => 10/327018
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4953
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20030095995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327018
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327018 | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents | Dec 19, 2002 | Abandoned |
Array
(
[id] => 6643159
[patent_doc_number] => 20030104021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'High electrolyte content W/O emulsions for treating irritated/sensitive skins'
[patent_app_type] => new
[patent_app_number] => 10/315041
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5566
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10315041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/315041 | High electrolyte content W/O emulsions for treating irritated/sensitive skins | Dec 9, 2002 | Abandoned |
Array
(
[id] => 6842612
[patent_doc_number] => 20030147959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Emulsion vehicle for poorly soluble drugs'
[patent_app_type] => new
[patent_app_number] => 10/299626
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10766
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299626
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299626 | Emulsion vehicle for poorly soluble drugs | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6710445
[patent_doc_number] => 20030170194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid'
[patent_app_type] => new
[patent_app_number] => 10/276766
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170194.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276766 | Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6855739
[patent_doc_number] => 20030129240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Method and non-gelling composition for inhibiting post-surgical adhesions'
[patent_app_type] => new
[patent_app_number] => 10/293464
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8736
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293464
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293464 | Method and non-gelling composition for inhibiting post-surgical adhesions | Nov 11, 2002 | Abandoned |
Array
(
[id] => 6855730
[patent_doc_number] => 20030129231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Sustained release oxycodone formulations with no fed/fast effect'
[patent_app_type] => new
[patent_app_number] => 10/272340
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5943
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272340 | Sustained release oxycodone formulations with no fed/fast effect | Oct 15, 2002 | Abandoned |
Array
(
[id] => 6668286
[patent_doc_number] => 20030113269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Medical combinations comprising tiotropium and fluticasone proprionate'
[patent_app_type] => new
[patent_app_number] => 10/257643
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2437
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257643 | Medical combinations comprising tiotropium and fluticasone proprionate | Oct 14, 2002 | Abandoned |